1. Home
  2. WGRX vs ADAP Comparison

WGRX vs ADAP Comparison

Compare WGRX & ADAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WGRX
  • ADAP
  • Stock Information
  • Founded
  • WGRX 2022
  • ADAP 2008
  • Country
  • WGRX United States
  • ADAP United Kingdom
  • Employees
  • WGRX N/A
  • ADAP N/A
  • Industry
  • WGRX Other Pharmaceuticals
  • ADAP Biotechnology: Pharmaceutical Preparations
  • Sector
  • WGRX Health Care
  • ADAP Health Care
  • Exchange
  • WGRX Nasdaq
  • ADAP Nasdaq
  • Market Cap
  • WGRX 66.1M
  • ADAP 75.5M
  • IPO Year
  • WGRX 2025
  • ADAP 2015
  • Fundamental
  • Price
  • WGRX $0.91
  • ADAP $0.10
  • Analyst Decision
  • WGRX
  • ADAP Hold
  • Analyst Count
  • WGRX 0
  • ADAP 6
  • Target Price
  • WGRX N/A
  • ADAP $1.02
  • AVG Volume (30 Days)
  • WGRX 2.3M
  • ADAP 11.4M
  • Earning Date
  • WGRX 08-11-2025
  • ADAP 08-11-2025
  • Dividend Yield
  • WGRX N/A
  • ADAP N/A
  • EPS Growth
  • WGRX N/A
  • ADAP N/A
  • EPS
  • WGRX N/A
  • ADAP N/A
  • Revenue
  • WGRX $28,992,274.00
  • ADAP $179,639,000.00
  • Revenue This Year
  • WGRX N/A
  • ADAP N/A
  • Revenue Next Year
  • WGRX N/A
  • ADAP $38.72
  • P/E Ratio
  • WGRX N/A
  • ADAP N/A
  • Revenue Growth
  • WGRX N/A
  • ADAP 878.53
  • 52 Week Low
  • WGRX $0.75
  • ADAP $0.10
  • 52 Week High
  • WGRX $7.04
  • ADAP $1.48
  • Technical
  • Relative Strength Index (RSI)
  • WGRX N/A
  • ADAP 27.44
  • Support Level
  • WGRX N/A
  • ADAP $0.10
  • Resistance Level
  • WGRX N/A
  • ADAP $0.36
  • Average True Range (ATR)
  • WGRX 0.00
  • ADAP 0.02
  • MACD
  • WGRX 0.00
  • ADAP -0.02
  • Stochastic Oscillator
  • WGRX 0.00
  • ADAP 0.62

About WGRX Wellgistics Health Inc. Common Stock

Wellgistics Health Inc is a healthcare technology and pharmaceutical logistics company. It simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. It is focused on improving the lives of patients while delivering unique solutions for pharmacies, providers, pharmaceutical manufacturers, and payors.

About ADAP Adaptimmune Therapeutics plc

Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.

Share on Social Networks: